case_images: PMC7174955_01
case_images: Ultrasonogram of the liver. (a) Before treatment: portal thrombus was seen in the right portal branch (arrow). (b) The thrombus was almost completely dissolved on day 6.
case_images: CRIM2020-8268016.001.jpg
case_images: PMC7174955_01_CRIM2020-8268016.001.jpg
case_images: fig1
case_images: The thrombi were locally scattered in the right branches, and hepatocellular carcinomas and ascites were not seen (Figures 1 and 2). D-dimer gradually declined (Figure 3) and the thrombus was almost completely dissolved (Figure 1). Due to the observation of a tendency for thrombolysis and a low serum level of AT III, we also injected 1500 IU of human AT III for 3 consecutive days, and sequentially, same dose of
case_images: CT images of the liver. (a) Before treatment: portal thrombi were locally scattered in the right portal branch (arrow). (b) The thrombi were not seen on day 16.
case_images: CRIM2020-8268016.002.jpg
case_images: PMC7174955_01_CRIM2020-8268016.002.jpg
case_images: fig2
case_images: The thrombi were locally scattered in the right branches, and hepatocellular carcinomas and ascites were not seen (Figures 1 and 2). TM-alpha for further 6 days. The level of D-dimer subsequently declined further (Figure 3), and the thrombus completely disappeared (Figure 2).
case_images: Changes in coagulation-related values. rhTM: recombinant human soluble thrombomodulin. AT III : antithrombin III.
case_images: CRIM2020-8268016.003.jpg
case_images: PMC7174955_01_CRIM2020-8268016.003.jpg
case_images: fig3
case_images: D-dimer gradually declined (Figure 3) and the thrombus was almost completely dissolved (Figure 1). Due to the observation of a tendency for thrombolysis and a low serum level of AT III, we also injected 1500 IU of human AT III for 3 consecutive days, and sequentially, same dose of TM-alpha for further 6 days. The level of D-dimer subsequently declined further (Figure 3), and the thrombus completely disappeared (Figure 2).